Abstract:In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where long-term survival is a critical outcome. These therapies, including immunotherapies or other advanced treatments, aim to establish durable effects. They often exhibit distinct survival patterns such as crossing or delayed separation and potentially leveling-off at the tails of survival curves, clearly violating the proportional hazards assumption and rendering the hazard ratio inappropriate for measuring treatment effects. The proposed methodology utilizes the mixture cure framework to separately analyze the cure rates of long-term survivors and the survival functions of susceptible individuals. We evaluate a nonparametric estimator for the susceptible survival function in the one-sample setting. Under sufficient follow-up, it is expressed as a location-scale-shift variant of the Kaplan-Meier (KM) estimator. It retains several desirable features of the KM estimator, including inverse-probability-censoring weighting, product-limit estimation, self-consistency, and nonparametric efficiency. In scenarios of insufficient follow-up, it can easily be adapted by incorporating a suitable cure rate estimator. In the two-sample setting, besides using the difference in cure rates to measure the long-term effect, we propose a graphical estimand to compare the relative treatment effects on susceptible subgroups. This process, inspired by Kendall's tau, compares the order of survival times among susceptible individuals. The proposed methods' large-sample properties are derived for further inference, and the finite-sample properties are examined through extensive simulation studies. The proposed methodology is applied to analyze the digitized data from the CheckMate 067 immunotherapy clinical trial.

Long‐term Survivor Model with Bivariate Random Effects: Applications to Bone Marrow Transplant and Carcinoma Study Data

Competing Risk Model with Bivariate Random Effects for Clustered Survival Data

Multilevel Mixture Cure Models with Random Effects

Modeling clustered long-term survivors using marginal mixture cure model.

Joint longitudinal and survival-cure models in tumour xenograft experiments.

On semiparametric transformation cure models

Extending the long-term survivor mixture model with random effects for clustered survival data

Estimand-based Inference in Presence of Long-Term Survivors

Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models

A New Mixture Model With Cure Rate Applied to Breast Cancer Data

Mixed-Effects Varying-Coefficient Model with Skewed Distribution Coupled with Cause-Specific Varying-Coefficient Hazard Model with Random-Effects for Longitudinal-Competing Risks Data Analysis

Marginal semiparametric accelerated failure time cure model for clustered survival data

A General Joint Model for Longitudinal Measurements and Competing Risks Survival Data with Heterogeneous Random Effects

Semiparametric multivariate joint model for skewed-longitudinal and survival data: A Bayesian approach

Stochastic EM algorithm for generalized exponential cure rate model and an empirical study

Random Effects Models for Analyzing Mixed Overdispersed Binomial and Normal Longitudinal Responses With Application to Kidney Function Data of Cancer Patients

A First Passage Time Model for Long-Term Survivors with Competing Risks

Semiparametric Additive Modeling of the Restricted Mean Survival Time

Modelling Survival Events with Longitudinal Data Measured with Error

A Bayesian joint model of multiple longitudinal and categorical outcomes with application to multiple myeloma using permutation-based variable importance

Semiparametric Estimation of the Cure Fraction in Population‐based Cancer Survival Analysis